Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Arcara, Gene Wright, John Tagliamonte

Neuromed Pharmaceuticals said this week that Jeffrey Arcara and Gene Wright have joined the company as vice president of business development and vice president of project leadership, respectively. Both are newly created positions.
Arcara comes to Neuromed from Wyeth, where he was executive director of marketing. Prior to Wyeth, Arcara was vice president of commercial operations at InKine Pharmaceuticals.
Wright previously worked for Schering-Plough as executive director and senior project leader of the antiviral/antifungal groups. Before that, Wright was vice president of CNS/pain development, project management, and pharmacokinetics at Biovail Technologies.

ImmunoGen said this week that John Tagliamonte has joined the Company as vice president of business development.

Before joining ImmunoGen, Tagliamonte was most recently senior director of strategy and corporate development at Millipore. Tagliamonte has also held positions at Laureate Pharma, Johnson & Johnson, PerkinElmer, and Bio-Rad Laboratories.

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.